Research Peptide

Melanotan I

Size: 10MG

Select product size
Melanotan I GREYLINE research vial
$59.982 vials · $29.99 per vial
Select quantity tier
2
VisaDiscoverMastercardAmerican ExpressApple PayBitcoin

For research use only. Not for human or veterinary use.

Product Description

Melanotan I is an established synonym for afamelanotide, a synthetic analog of alpha-melanocyte-stimulating hormone. PubChem, FDA labeling, and peer-reviewed clinical literature identify that compound, while the approved afamelanotide product is a subcutaneous implant with its own formulation. Those records do not authenticate this lyophilized catalog vial.

Certificate of Analysis

Lot-specific analytical results and downloadable documentation

LOT-SPECIFICNO DOCUMENT ON FILE
—Verified purity resultCOA unavailable
Product
Melanotan I
Lot number
—
Test date
—
Purity (HPLC)
—
Identity
—
Net content
—
Sterility
—
Endotoxin
—

Related research compounds

Third-party tested
Melanotan II research vial

Melanotan II

From $29.99

Research Peptide

Third-party tested
PT-141 research vial

PT-141

From $29.99

Cellular Peptide

Third-party tested
GHK-CU research vial

GHK-CU

From $29.99

Dermal Compound

Third-party tested
SNAP-8 research vial

SNAP-8

From $29.99

Dermal Peptide

Third-party tested
BPC-157 research vial

BPC-157

From $39.99

Cellular Peptide

Third-party tested
TB-500 research vial

TB-500

From $39.99

Cellular Peptide

Third-party tested
NAD+ research vial

NAD+

From $69.99

Cellular Compound

Third-party tested
AOD-9604 research vial

AOD-9604

From $49.99

Cellular Peptide

Compound Information

Technical specifications

Molecular Profile

What is Melanotan I?

Type
Synthetic linear α-MSH peptide analog
CAS number
75921-69-6
Molecular weight
1646.8 g/mol
Amino acids
13
Molecular formula
C78H111N21O19
PubChem: Afamelanotide
Storage Requirements

Stability Information

Formulation-specific stability unknownProtect from lightKeep sealed and dry
Lyophilized / unopenedNo product-specific shelf life supplied; follow a qualified laboratory SOP.
Reconstituted / in solutionNo authoritative hold time supplied; use a validated laboratory protocol.

The FDA-approved afamelanotide implant's storage requirements are product-specific and cannot be assigned to this differently presented catalog vial.

Sources & References

Peer-reviewed and authoritative records

New England Journal of Medicine

Primary clinical research

Afamelanotide for Erythropoietic Protoporphyria

2015·DOI: 10.1056/NEJMoa1411481

Langendonk JG, Balwani M, Anderson KE, Bonkovsky HL, Anstey AV, Bissell DM, et al.

View Source

Photodermatology, Photoimmunology & Photomedicine

Primary clinical research

German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP)

2025·DOI: 10.1111/phpp.13012

Homey B, Schelonke K, Schlegel CM, Bruch-Gerharz D, Weller K, Kiefer L, Stölzel U, Staubach-Renz P, Wegner J, Keller-Melchior R, Walker G, Bochno M, Bilbao P

View Source

Important Research Notice

Not for human consumption. This product is sold exclusively for laboratory, analytical, and educational research purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

Research information presented on this page is provided for educational reference and should not be interpreted as medical advice or as a product claim.

By purchasing this product, the customer confirms that it will be handled and used only by qualified individuals in accordance with all applicable laws and laboratory procedures.

Premium research peptides,
refined for modern researchers.

High purity. Verified quality. Trusted by researchers worldwide.

Shop Now